| Literature DB >> 35392562 |
Fangyu Xiao1, Jihua Qiu2, Ying Zhao1,3,4.
Abstract
Objective: This study focuses on whether vine tea contains potentially toxic components that trigger hepatotoxicity as a mechanism of action, which further provides some reference for the consumption and guides future product development of vine tea.Entities:
Keywords: GEO database; hepatotoxicity; molecular docking; molecular dynamics; network toxicology; vine tea
Year: 2022 PMID: 35392562 PMCID: PMC8981030 DOI: 10.3389/fphar.2022.855926
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Potentially toxic components of vine tea.
| Pubchem ID | Name | CAS ID | MeSH® ID | |
|---|---|---|---|---|
| 1 | 161557 | Dihydromyricetin | 27200-12-0 |
|
| 2 | 5281672 | Myricetin | 529-44-2 |
|
| 3 | 439533 | Taxifolin | 480-18-2 |
|
| 4 | 5280863 | Kaempferol | 520-18-3 |
|
| 5 | 10639 | Physcion | 521-61-9 |
|
| 6 | 122850 | Dihydrokaempferol | 480-20-6 |
|
| 7 | 5280343 | Quercetin | 117-39-5 |
|
| 8 | 6072 | Phloridzin | 60-81-1 |
|
| 9 | 4788 | Phloretin | 60-82-2 |
|
| 10 | 72281 | Hesperitin | 520-33-2 |
|
| 11 | 72320 | Nomilin | 1063-77-0 |
|
| 12 | 5280450 | Linoleic acid | 2197-37-7 |
|
| 13 | 5281 | Octadecanoic acid | 57-11-4 |
|
| 14 | 985 | Palmitic acid | 57-10-3 |
|
| 15 | 5280934 | Linolenic acid | 463-40-1 | D008042 |
| 16 | 6184 | Hexanal | 66-25-1 |
|
| 17 | 31289 | Nonanal | 124-19-6 |
|
| 18 | 5283321 | (E, E)-2,4-heptadienal | 4313-03-5 | C502503 |
| 19 | 638014 | Beta-ionone | 14901-07-6 |
|
| 20 | 8063 | Pentanal | 110-62-3 |
|
| 21 | 454 | Octanal | 124-13-0 |
|
| 22 | 5283324 | 2-Octenal | 2548-87-0 |
|
| 23 | 8175 | Decanal | 112-31-2 |
|
| 24 | 6549 | Linalool | 78-70-6 |
|
| 25 | 8186 | Undecanal | 112-44-7 |
|
| 26 | 61041 | Safranal | 116-26-7 |
|
| 27 | 17100 | Alpha-terpineol | 98-55-5 |
|
| 28 | 638011 | Citral | 5392-40-5 |
|
| 29 | 5283349 | 2,4-Decadienal | 25152-84-5 |
|
| 30 | 4133 | Methyl salicylate | 119-36-8 |
|
| 31 | 8892 | Hexanoic acid | 142-62-1 |
|
| 32 | 8094 | Heptanoic acid | 111-14-8 |
|
| 33 | 379 | Octanoic acid | 124-07-2 |
|
| 34 | 8158 | Nonanoic acid | 112-05-0 |
|
FIGURE 1Hepatic toxicity targets protein–protein interaction network. Nodes are hepatotoxic targets; edges are target protein interactions.
FIGURE 2GO enrichment analysis of hepatotoxic target.
KEGG enrichment pathway of hepatotoxic target genes.
| Pathway ID | Pathway description | P.adjust | Count |
|---|---|---|---|
| hsa05219 | Bladder cancer | 8.7 × 10−7 | 7 |
| hsa01522 | Endocrine resistance | 1.2 × 10−5 | 8 |
| hsa05418 | Fluid shear stress and atherosclerosis | 9.5 × 10−5 | 8 |
| hsa05215 | Prostate cancer | 9.5 × 10−5 | 7 |
| hsa04066 | HIF-1 signaling pathway | 1.6 × 10−4 | 7 |
| hsa05224 | Breast cancer | 9.4 × 10−4 | 7 |
| hsa05205 | Proteoglycans in cancer | 9.4 × 10−4 | 8 |
| hsa05216 | Thyroid cancer | 1.7 × 10−3 | 4 |
| hsa01524 | Platinum drug resistance | 1.7 × 10−3 | 5 |
| hsa05212 | Pancreatic cancer | 1.8 × 10−3 | 5 |
| hsa05206 | MicroRNAs in cancer | 1.8 × 10−3 | 9 |
| hsa04211 | Longevity regulating pathway | 3.3 × 10−3 | 5 |
| hsa05213 | Endometrial cancer | 6.3 × 10−3 | 4 |
| hsa05225 | Hepatocellular carcinoma | 7.7 × 10−3 | 6 |
| hsa04919 | Thyroid hormone signaling pathway | 1.1 × 10−2 | 5 |
| hsa05223 | Non-small-cell lung cancer | 1.1 × 10−2 | 4 |
| hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.3 × 10−2 | 6 |
| hsa04610 | Complement and coagulation cascades | 1.8 × 10−2 | 4 |
| hsa05210 | Colorectal cancer | 1.8 × 10−2 | 4 |
| hsa05226 | Gastric cancer | 2.0 × 10−2 | 5 |
| hsa05222 | Small-cell lung cancer | 2.1 × 10−2 | 4 |
| hsa05160 | Hepatitis C | 2.3 × 10−2 | 5 |
| hsa05165 | Human papillomavirus infection | 3.4 × 10−2 | 7 |
| hsa00480 | Glutathione metabolism | 4.0 × 10−2 | 3 |
| hsa01200 | Carbon metabolism | 4.4 × 10−2 | 4 |
| hsa04213 | Longevity-regulating pathway- multiple species | 4.6 × 10−2 | 3 |
Molecular docking parameters.
| Gene | Protein | PDB ID | Positive ligand Pubchem id | RMSD(Å) | Source ligand score (kcal/mol) |
|---|---|---|---|---|---|
| VEGFA | Vascular endothelial growth factor A | 3BDY | 56603655 | — | — |
| CAT | Catalase | 1DGF | 15559239 | 0.7133 | −9.45 |
| MMP9 | Matrix metalloproteinase-9 | 1GKC | 54671203 | 0.7383 | −6.69 |
| PPARG | Peroxisome proliferator-activated receptor | 3NOA | 3651377 | 0.3112 | −10.02 |
| HMOX1 | Heme oxygenase 1 | 6EHA | 4971 | 0.3605 | −5.94 |
| NOTCH1 | Neurogenic locus notch homolog protein 1 | 2F8X | 43815 | — | — |
| SOD2 | Superoxide dismutase [Mn], mitochondrial | 1ZTE | 29327 | — | — |
| ESR1 | Estrogen receptor | 5ACC | 104741 | 0.2131 | −7.25 |
| CCND1 | G1/S-specific cyclin-D1 | 2W96 | 119307 | — | — |
| MMP2 | 72 kDa type IV collagenase | 1RTG | 23310222 | — | — |
| NOS2 | Nitric oxide synthase, inducible | 4N0S | 2146 | 0.4876 | −3.41 |
| CTNNB1 | Catenin beta-1 | 1P22 | 40486 | - | - |
| AR | Androgen receptor | 3RLJ | 67171867 | 0.3687 | −7.87 |
| DNMT1 | DNA (cytosine-5)-methyltransferase 1 | 3SWR | 702558 | 0.431 | −7.98 |
| ERBB2 | Receptor tyrosine-protein kinase erbB-2 | 3RCD | 5280343 | 0.3687 | −8.97 |
| TP53 | Cellular tumor antigen p53 | 5BUA | 6450226 | — | — |
Molecular docking of potentially toxic components of vine tea.
| PDB ID | Pocket size (Xmin Xmax, Ymin Ymax, Zmin Zmax) | Pubchem id | Score (kcal/mol) |
|---|---|---|---|
| 3BDY | -55.137 -43.843,-63.747 -51.128,-6.532 6.32 | 56603655 | −6.12 |
| 1DGF | 17.059 37.69,65.515 85.329,60.61 78.625 | 15559239 | −5.71 |
| 72281 | −6.21 | ||
| 5281672 | −6.22 | ||
| 6072 | −8.42 | ||
| 1GKC | 57.951 73.263,23.793 38.373,108.689 126.996 | 54671203 | −5.88 |
| 161557 | −6.09 | ||
| 5281672 | −6.43 | ||
| 6072 | −7.22 | ||
| 5280343 | −6.14 | ||
| 3NOA | -17.606 -1.512,-1.912 13.828,27.491 52.487 | 3651377 | −5.17 |
| 161557 | −6.26 | ||
| 5280863 | −6.07 | ||
| 5281672 | −6.31 | ||
| 6072 | −7.74 | ||
| 5280343 | −6.35 | ||
| 439533 | −6.29 | ||
| 6EHA | 8.197 22.295,-8.896 6.105,25.248 42.982 | 4971 | −4.75 |
| 4788 | −6.35 | ||
| 5280343 | −6.12 | ||
| 2F8X | 79 103,51 85,-22 14 | 43815 | −6.55 |
| 122850 | −6.06 | ||
| 161557 | −6.55 | ||
| 5280863 | −6.12 | ||
| 5281672 | −6.57 | ||
| 4788 | −6.45 | ||
| 6072 | −8.63 | ||
| 5280343 | −6.22 | ||
| 439533 | −6.21 | ||
| 1ZTE | 26 46,-1.1 16.9,51 67 | 29327 | −5.49 |
| 6072 | −7.04 | ||
| 5ACC | 5.996 22.284,13.209 31.381,57.414 75.909 | 104741 | −6.36 |
| 6072 | −6.66 | ||
| 2W96 | -1 25,-10 16,19 45 | 119307 | −4.56 |
| 1RTG | 10 30,20 36,7.5 21.5 | 23310222 | −5.2 |
| 6072 | −6.4 | ||
| 4N0S | -22.432 -7.127,5.408 20.213,34.982 46.184 | 2146 | −3.15 |
| 6072 | −6.8 | ||
| 1P22 | -15 5,18 38,-23 -3 | 40486 | −6.79 |
| 72320 | −6.13 | ||
| 6072 | −6.97 | ||
| 3RLJ | 19.021 34.81,-4.706 11.518,-0.91 16.722 | 67171867 | −8.34 |
| 161557 | −6.7 | ||
| 72281 | −6.03 | ||
| 5280863 | −6.03 | ||
| 5281672 | -6.14 | ||
| 4788 | -6.6 | ||
| 6072 | −6.16 | ||
| 5280343 | −6.5 | ||
| 439533 | −6.32 | ||
| 3SWR | -12.867 2.786,-10.553 8.655,23.049 40.581 | 702558 | −6.64 |
| 161557 | −6.78 | ||
| 5281672 | −6.65 | ||
| 4788 | −6.38 | ||
| 6072 | −7.95 | ||
| 5280343 | −6.62 | ||
| 3RCD | 2.899 22.061,-7.118 13.045,19.662 36.368 | 5280343 | −5.99 |
| 161557 | −6.06 | ||
| 5281672 | −6.45 | ||
| 6072 | −7.06 | ||
| 5BUA | 91.7 111.7,69.5 89.5,-24.9 -4.9 | 6450226 | −3.89 |
| 6072 | −6.37 |
FIGURE 3Results of 10 ns simulation of 1DGF and Phloridzin. Graph (A) indicates the RMSD variation of protein residue-ligand within 10 ns with the ligand as the center expanding 5 nm; graph (B) indicates the change in the value of hydrogen bonding generated by this ligand with protein residues within 10 ns.
FIGURE 4Venn diagram of transcriptome analysis. Graph (A) indicates the distribution of GO functions enriched by vine tea components as perturbation factors similar to the GO functions enriched by the reference expression profile; graph (B) indicates the intersection of transcriptional targets hit by hepatotoxic targets and liver injury-related GO functions.
Gene set correlation and hit count of GO similar functional modules.
| Compound | GO ID | Description | Relativity | Counts |
|---|---|---|---|---|
| Quercetin | GO:0000302 | Response to reactive oxygen species | 0.745 | 33 |
| GO:0034614 | Cellular response to reactive oxygen species | 0.721 | 21 | |
| GO:0010035 | Response to inorganic substance | 0.793 | 50 | |
| GO:0034097 | Response to cytokine | 0.78 | 50 | |
| GO:0071407 | Cellular response to organic cyclic compound | 0.727 | 26 | |
| GO:0009636 | Response to toxic substance | 0.746 | 50 | |
| GO:0071363 | Cellular response to growth factor stimulus | 0.741 | 26 | |
| GO:0070848 | Response to growth factor | 0.783 | 50 | |
| GO:0098754 | Detoxification | 0.667 | 50 | |
| GO:0044344 | Cellular response to fibroblast growth factor stimulus | 0.702 | 26 | |
| Taxifolin | GO:0009611 | Response to wounding | 0.747 | 60 |
| GO:0006979 | Response to oxidative stress | 0.77 | 64 | |
| GO:0071900 | Regulation of protein serine/threonine kinase activity | 0.619 | 5 | |
| GO:0043069 | Negative regulation of programmed cell death | 0.608 | 8 | |
| GO:0060548 | Negative regulation of cell death | 0.636 | 11 | |
| GO:0070997 | Neuron death | 0.675 | 12 | |
| GO:1901215 | Negative regulation of neuron death | 0.669 | 11 | |
| GO:0043524 | Negative regulation of the neuron apoptotic process | 0.653 | 10 | |
| GO:0043523 | Regulation of the neuron apoptotic process | 0.668 | 12 | |
| Phloridzin | GO:0010035 | Response to inorganic substance | 0.656 | 10 |
| GO:0071407 | Cellular response to organic cyclic compound | 0.787 | 41 | |
| GO:0009611 | Response to wounding | 0.665 | 17 | |
| GO:0033993 | Response to lipid | 0.768 | 24 | |
| GO:0071902 | Positive regulation of protein serine/threonine kinase activity | 0.718 | 11 | |
| GO:0071900 | Regulation of protein serine/threonine kinase activity | 0.71 | 11 | |
| GO:0043066 | Negative regulation of the apoptotic process | 0.804 | 34 | |
| GO:1901568 | Fatty acid derivative metabolic process | 0.709 | 72 | |
| GO:0006690 | Icosanoid metabolic process | 0.638 | 6 | |
| GO:0043065 | Positive regulation of the apoptotic process | 0.758 | 23 | |
| GO:0043523 | Regulation of the neuron apoptotic process | 0.745 | 23 | |
| Kaempferol | GO:0000302 | Response to reactive oxygen species | 0.85 | 62 |
| GO:0071407 | Cellular response to the organic cyclic compound | 0.856 | 97 | |
| GO:0009611 | Response to wounding | 0.848 | 75 | |
| GO:0006631 | Fatty acid metabolic process | 0.676 | 31 | |
| GO:0006979 | Response to oxidative stress | 0.864 | 75 | |
| GO:0071345 | Cellular response to cytokine stimulus | 0.908 | 144 | |
| GO:0071900 | Regulation of protein serine/threonine kinase activity | 0.712 | 13 | |
| GO:0043066 | Negative regulation of the apoptotic process | 0.678 | 6 | |
| GO:0051402 | Neuron apoptotic process | 0.696 | 7 | |
| GO:0071902 | Positive regulation of protein serine/threonine kinase activity | 0.729 | 13 | |
| GO:0044255 | Cellular lipid metabolic process | 0.708 | 38 | |
| GO:0071363 | Cellular response to growth factor stimulus | 0.911 | 128 | |
| GO:0070848 | Response to growth factor | 0.91 | 128 | |
| GO:0080135 | Regulation of cellular response to stress | 0.84 | 34 | |
| GO:0043065 | Positive regulation of the apoptotic process | 0.686 | 6 | |
| GO:0002237 | Response to the molecule of bacterial origin | 0.883 | 85 | |
| GO:0043523 | Regulation of the neuron apoptotic process | 0.689 | 6 |